858
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents

, , , , , & show all
Pages 347-364 | Received 24 Aug 2015, Accepted 08 Dec 2015, Published online: 06 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesca Patriarca, Luisa Giaccone, Francesco Onida, Luca Castagna, Barbara Sarina, Vittorio Montefusco, Alberto Mussetti, Nicola Mordini, Elena Maino, Raffaella Greco, Jacopo Peccatori, Moreno Festuccia, Francesco Zaja, Stefano Volpetti, Antonio Risitano, Renato Bassan, Paolo Corradini, Fabio Ciceri, Renato Fanin, Michele Baccarani, Alessandro Rambaldi, Francesca Bonifazi & Benedetto Bruno. (2017) New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?. Expert Opinion on Biological Therapy 17:7, pages 821-836.
Read now

Articles from other publishers (3)

Lichuan Wu, Ke Ye, Sheng Jiang & Guangbiao Zhou. (2021) Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms. Marine Drugs 19:9, pages 488.
Crossref
L Giaccone, M Festuccia, F Zallio, R Sorasio, L Brunello, E Maffini, C Dellacasa, R Passera, G Iovino, S Aydin, M Boccadoro, U Vitolo, N Mordini, M Pini, A Busca & B Bruno. (2017) Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Bone Marrow Transplantation 52:8, pages 1208-1211.
Crossref
L Hegerova, Q Cao, A Lazaryan, B L McClune, D J Weisdorf, C G Brunstein & V Bachanova. (2017) Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era. Bone Marrow Transplantation 52:5, pages 697-703.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.